Zdrowie i gospodarka · 28/01/2022

FDA Extends Comment Period for Draft Guidance on Computational Modeling and Simulation in Medical Device Submissions

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on assessing the credibility of computational modeling and simulation in medical device submissions, allowing industry and FDA staff more time to provide feedback.